Seer Inc (SEER) USD0.00001 A
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product Suite (Proteograph), is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. Proteograph leverages its engineered nanoparticle (NP) technology to provide large-scale access to the proteome. Its engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide level, including protein variants. It is focused on adoption of the Proteograph with customers in the proteomics and genomics markets. The Company is initially focused on research applications for the Proteograph product suite and is selling and marketing the Proteograph for research use only (RUO).
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.